• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    Synta Pharmaceuticals Corp. (SNTA)

    -NasdaqGM
    2.86 Up 0.14(5.15%) 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue -   147   7,584  
    Cost of Revenue -   -   -  
    Gross Profit -   147   7,584  
    Operating Expenses
    Research Development71,860  49,412  41,464  
    Selling General and Administrative15,699  11,676  11,552  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (87,559) (60,941) (45,432)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -  
    Earnings Before Interest And Taxes(87,559)(60,941)(45,432)
    Interest Expense2,633  1,849  1,948  
    Income Before Tax(90,192)(62,790)(47,380)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(90,192)(62,790)(47,380)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (90,192) (62,790) (47,380)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (90,192) (62,790) (47,380)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.